1184. A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13™ with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)

BACKGROUND: Pneumococcal diseases (PD) caused by Streptococcus pneumoniae are a major health concern globally. In children, currently licensed pneumococcal conjugate vaccines (PCVs) provide protection against PD from vaccine serotypes, but other non-vaccine serotypes have emerged and contribute to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bili, Adroniki, Dobson, Scott, Quinones, Jeffrey, Phongsamart, Wanatpreeya, Oberdorfer, Peninnah, Kosalaraksa, Pope, Dagan, Ron, Wilck, Marissa B, Vallejos, Waldimir, Nunn, Christine, McFetridge, Richard, Fu, Rong, Lupinacci, Robert, Musey, Luwy, Bickham, Kara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644774/
http://dx.doi.org/10.1093/ofid/ofab466.1376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644774/
http://dx.doi.org/10.1093/ofid/ofab466.1376

Ejemplares similares